A Study of Ad26.COV2.S in Adults (COVID-19)

Clinical trial NCT04436276 · COMPLETED

Trial details

NCT number: NCT04436276
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Covid-19 Prevention

Start date: 2020-07-15
Primary completion: 2023-02-21
Enrollment: 1085

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.